SCHEDULE 13D/AAccepted Mar 25, 4:05 PM ET
Theravance Biopharma, Inc. SCHEDULE 13D/A
Accepted (ET)
4:05 PM
Mar 25, 2026
Filed
Mar 25, 2026
Documents
1
Size
12.6 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.